Suppr超能文献

δ非劣效界值的选择及非劣效性试验的依赖性

Choice of delta noninferiority margin and dependency of the noninferiority trials.

作者信息

Tsong Yi, Zhang Joanne, Levenson Mark

机构信息

Division of Biometrics VI, Office of Biostatistics, Office of Translational Sciences, CDER, FDA, Silver Spring, MD 20993-0002, USA.

出版信息

J Biopharm Stat. 2007;17(2):279-88. doi: 10.1080/10543400601177384.

Abstract

For a two-arm active control clinical trial designed to test for noninferiority of the test treatment to the active control standard treatment, data of historical studies were often used. For example, with a cross-trial comparison approach (also called synthetic approach or lambda-margin approach), the trial is conducted to test the hypothesis that the mean difference or the ratio between the current test product and the active control is no larger than a certain portion of the mean difference or no smaller that a certain portion of the ratio of the active control and placebo obtained in the historical data when the positive response indicates treatment effective. For a generalized historical control approach (also known as confidence interval approach or delta -margin approach), the historical data is often used to determine a fixed value noninferiority margin delta for all trials involving the active control treatment. The regulatory agency usually requires that the clinical trials of two different test treatments need to be independent and in most regular cases, it also requires to have two independent positive trials of the same test treatment in order to provide confirmatory evidence of the efficacy of the test product. Because of the nature of information (historical data) shared in active-controlled trials, the independency assumption of the trials is not satisfied in general. The correlation between two noninferiority tests has been examined which showed that it is an increasing function of (1 - lambda ) when the response variable is normally distributed. In this article, we examine the relationship between the correlation of the two test statistics and the choice of the noninferiority margin, delta as well as the sample sizes and variances under the normality assumption. We showed that when delta is determined by the lower limit of the confidence interval of the adjusted effect size of the active control treatment (muC - muP) using data from historical studies, dependency of the two noninferiority tests can be very high. In order to control the correlation under 15%, the overall sample size of the historical studies needs to be at least five times of the current active control trial.

摘要

对于旨在检验试验治疗相对于活性对照标准治疗的非劣效性的双臂活性对照临床试验,常常会使用历史研究的数据。例如,采用交叉试验比较方法(也称为综合方法或λ-界值方法)进行试验,以检验以下假设:当阳性反应表明治疗有效时,当前试验产品与活性对照之间的均值差或比值不大于历史数据中活性对照与安慰剂比值的某一特定部分的均值差,或不小于该比值的某一特定部分。对于广义历史对照方法(也称为置信区间方法或δ-界值方法),历史数据通常用于为所有涉及活性对照治疗的试验确定一个固定值的非劣效性界值δ。监管机构通常要求两种不同试验治疗的临床试验相互独立,并且在大多数常规情况下,还要求对同一试验治疗进行两项独立的阳性试验,以提供试验产品疗效的确证性证据。由于活性对照试验中共享的信息(历史数据)的性质,试验的独立性假设通常无法满足。已经对两个非劣效性检验之间的相关性进行了研究,结果表明,当反应变量呈正态分布时,它是(1 - λ)的增函数。在本文中,我们在正态性假设下研究了两个检验统计量的相关性与非劣效性界值δ的选择以及样本量和方差之间的关系。我们表明,当δ由使用历史研究数据的活性对照治疗的调整效应大小(μC - μP)的置信区间下限确定时,两个非劣效性检验的依赖性可能会非常高。为了将相关性控制在15%以下,历史研究的总体样本量需要至少是当前活性对照试验的五倍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验